Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Utility of AMOY polymerase chain reaction panel in detecting non-small cell lung cancer using pleural cell block.

Japanese journal of clinical oncology - 7 May 2026

Murakami Shuji, Shinada Kanako, Otsuzumi Yuka, Sato Shinya, Komine Fumiko, Yuan Yuan, Nakamura Junko, Katakura Seigo, Kondo Tetsuro, Yokose Tomoyuki, Saito Haruhiro

Abstract excerpt

BACKGROUND: Comprehensive biomarker testing is mandatory for advanced non-small cell lung cancer (NSCLC). Pleural effusion cell blocks are a minimally invasive alternative to biopsy. The AmoyDx pan lung cancer (PLC) polymerase chain reaction panel is a sensitive multiplex assay; however, its performance using pleural cell-block specimens with low tumor-cell content remains largely unexplored. METHODS: We...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged
Share to Aged, 80 and over

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Biomarkers, Tumor

Share to Carcinoma, Non-Small-Cell Lung

Share to Lung Neoplasms

Share to Mutation

Share to Pleural Effusion, Malignant

Share to Polymerase Chain Reaction

Source

Identifiers

PMID: 41587234
DOI: 10.1093/jjco/hyag003

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Utility of AMOY polymerase chain reaction panel in detecting non-small cell lung cancer using pleural cell block.PMID 41587234Read ↗

Suitability of frozen cell pellets from cytology specimens for the Amoy 9-in-1 assay in patients with non-small cell lung cancer.Semantic proximity Read ↗

High Yield of Pleural Cell-Free DNA for Diagnosis of Oncogenic Mutations in Lung Adenocarcinoma.Semantic proximity Read ↗

From Basics to Benchmarks: Evaluating Sample Adequacy, PD-L1 Expression, and Molecular Profiling in Effusion Samples of Lung Adenocarcinoma.Semantic proximity Read ↗

EGFR testing in paraffin-embedded cell block cytology material is reliable with increased detection for effusion fluid.Semantic proximity Read ↗

Comprehensive Genomic Profiling of Malignant Effusions in Patients with Metastatic Lung Adenocarcinoma.Semantic proximity Read ↗

Clinical application of the Lung Cancer Compact PanelTM using various types of cytological specimens in patients with lung cancer.Semantic proximity Read ↗

Feasibility of EBUS-TBNA for histopathological and molecular diagnostics of NSCLC-A retrospective single-center experience.Semantic proximity Read ↗

Testing for EGFR Variants in Pleural and Pericardial Effusion Cell-Free DNA in Patients With Non-Small Cell Lung Cancer.Semantic proximity Read ↗

Molecular analysis of non-small cell lung cancer using a dual-targeted DNA and RNA comprehensive genomic profiling panel.Semantic proximity Read ↗

Diagnostic molecular biomarkers for malignant pleural effusions.Semantic proximity Read ↗

Comparison between next-generation sequencing and multiplex polymerase chain reaction assays for nonsmall-cell lung cancer molecular diagnosis.Semantic proximity Read ↗

Role of molecular testing for malignant pleural effusion in targeted therapy for advanced non-small cell lung cancer.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.